← Back to Clinical Trials
Recruiting NCT05742360

NCT05742360 Effect of CPAP on Blood Pressure in Excessively Sleepy Obstructive Sleep Apnea Subtype

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT05742360
Status Recruiting
Phase
Sponsor Ohio State University
Condition Obstructive Sleep Apnea
Study Type OBSERVATIONAL
Enrollment 227 participants
Start Date 2023-02-07
Primary Completion 2027-03-01

Trial Parameters

Condition Obstructive Sleep Apnea
Sponsor Ohio State University
Study Type OBSERVATIONAL
Phase N/A
Enrollment 227
Sex ALL
Min Age 18 Years
Max Age 75 Years
Start Date 2023-02-07
Completion 2027-03-01
Interventions
CPAP therapy

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

Brief Summary

The primary objective of this study is to determine the longer-term (6 months) effect of CPAP therapy on change in 24-hour mean blood pressure (24hMBP) in OSA subjects with the excessively sleepy symptom subtype.

Eligibility Criteria

Inclusion Criteria: * Age 18-75 years * Moderate-severe OSA (defined as ODI ≥10 events/hour) via Polysomnography (PSG) or Home Sleep Apnea Study (HSAT) done based on clinical grounds * Excessively sleepy subtype determined by patient-reported symptoms * Willing to accept CPAP therapy * An elevated baseline office BP defined as ≥120 or ≥80 mmHg * Planned PAP (CPAP or bi-level PAP) treatment by treating provider Exclusion Criteria: * Recent changes (within 3 months) to BP medications among those who are on these medications * Unable to apply ABPM cuff * Current use of CPAP or other OSA treatments * Resting, awake SaO2 \<90% or use of home oxygen therapy * New York Heart Association (NYHA) categories III-IV of heart failure * Presence of Cheyne-Stokes Respiration (CSR) in sleep study identified by typical crescendo-decrescendo pattern of respiration with associated apneas and/or hypopneas in the absence of inspiratory flow limitation * Predominantly central sleep apnea (AHI≥15 events/hour

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: April 2026  ·  Data Methodology